Acquiring Company
MaxCyte
Acquired Company
Akron BioProducts
RockvilleBoca RatonBiotechnologyHealth CareManufacturingBiotechnologyDescription
MaxCyte has entered into a definitive agreement to acquire Akron BioProducts LLC from affiliates of Arcline Investment Management for total consideration of $151.8 million. Akron is expected to generate approximately $28 million in revenue and $7-8 million in EBITDA in 2026, and the deal is expected to nearly double MaxCyte's revenue base. The transaction is expected to close before the end of 2026, subject to customary closing conditions, and MaxCyte secured a credit facility of up to $75.0 million with MidCap Financial to help fund the combined company.
Who to call at MaxCyte, and when
When MaxCyte changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day MaxCyte raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MaxCyte, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MaxCyte. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MaxCyte makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Akron BioProducts?
Akron BioProducts was acquired by MaxCyte, based in Rockville. The deal was reported on November 10, 2026. At MaxCyte, we pursue cell engineering excellence to maximize the potential of cells to improve patients’ lives. MaxCyte is privately held and operates in Biotechnology.
When did MaxCyte acquire Akron BioProducts?
MaxCyte's acquisition of Akron BioProducts was reported on November 10, 2026. MaxCyte has entered into a definitive agreement to acquire Akron BioProducts LLC from affiliates of Arcline Investment Management for total consideration of $151.8 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Akron BioProducts do?
Akron BioProducts (Akron Bio) is a leading supplier of GMP-grade reagents and ancillary materials used across the cell therapy manufacturing workflow. The company is known for its Closed System Solutions (CSS)® and drug master files supporting INDs and BLAs. It is privately held, operating in Manufacturing, and is based in Boca Raton.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.